Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Anticancer agents and apoptosis]

K Fukuoka, N Saijo

Nihon Rinsho. Japanese Journal of Clinical Medicine

|January 1, 1996

Summary

This summary is machine-generated.

The bcl-2 oncogene inhibits apoptosis, making cancer cells resistant to certain chemotherapy drugs like CPT-11 and MMC. This suggests bcl-2 impacts specific cancer cell death pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance.

Neuropathology and applied neurobiology·2019

Same author

Effects of Subnormothermic Perfusion Before Transplantation for Liver Grafts from Donation After Cardiac Death: A Simplified Dripping Perfusion Method in Pigs.

Transplantation proceedings·2018

Same author

Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Same author

Reinforcing apoptosis-resistance of COS and myeloma cells by transfecting with bcl-2 gene.

Cytotechnology·2012

Same author

Suppressive effect of asbestos on cytotoxicity of human NK cells.

International journal of immunopathology and pharmacology·2011

Area of Science:

Oncology
Cellular Biology
Immunology

Context:

Apoptosis, or programmed cell death, is crucial in oncology, immunology, and developmental biology.
Anticancer chemotherapy effectiveness can be influenced by programmed cell death mechanisms.
The role of the bcl-2 oncogene in modulating chemotherapy-induced apoptosis requires further investigation.

Purpose:

To investigate if the bcl-2 oncogene can inhibit chemotherapy-induced apoptosis.
To determine the impact of bcl-2 expression on the sensitivity of small cell lung cancer cells to various anticancer agents.

Summary:

A bcl-2 transfected human small cell lung cancer cell line (SBC-3/Bcl-2) was established and compared to the parental line (SBC-3).
SBC-3/Bcl-2 exhibited increased resistance to ADM, CPT-11, and MMC, with reduced DNA fragmentation compared to SBC-3.

Related Experiment Videos

No significant difference in sensitivity was observed for CDDP, VP-16, ACNU, MTX, and Taxol, indicating bcl-2-dependent and independent apoptotic pathways.

Impact:

Results suggest bcl-2 can modulate the cytotoxicity of specific anticancer drugs by inhibiting apoptosis.
This finding implies that some apoptotic pathways are regulated by bcl-2, while others are not.
Understanding these pathways could inform the development of more effective cancer therapies.